GlassScriptPhysician profile
Tammy L Herrick
NPI 1760635759
$847.72
in general payments reported to CMS, 2019-2025
19 companies · $62.64 in 2025
The $62.64 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $309 · 2020: $114 · 2021: $65.73 · 2022: $127 · 2023: $125 · 2024: $44.90 · 2025: $62.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $219 · Education: $12.80.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $219.40 |
| Education | $12.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $182.65 | 2019-2022 | |
| Astellas Pharma US INC | $128.01 | 2019-2025 | Veozah |
| Hologic Sales and Service, LLC | $90.10 | 2023-2024 | Novasure, Acessa Provu System, Myosure Tissue Removal Device |
| Pfizer INC. | $85.30 | 2019-2022 | |
| Aspira Women'S Health INC | $61.67 | 2022-2024 | Ova1 |
| Merck Sharp & Dohme LLC | $48.64 | 2019-2023 | Gardasil 9 |
| Bayer Healthcare Pharmaceuticals INC. | $34.74 | 2019-2025 | |
| Pacira Pharmaceuticals Incorporated | $30.76 | 2023 | Exparel |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.28 | 2019 | |
| Mylan Pharmaceuticals INC. | $26.29 | 2020-2021 | |
| Therapeuticsmd, INC. | $24.11 | 2019 | |
| Daiichi Sankyo INC. | $17.84 | 2019 | |
| Minerva Surgical, INC | $14.99 | 2021 | |
| Coopersurgical, INC. | $14.37 | 2019 | |
| Monaghan Medical Corporation | $13.11 | 2023 | Aerobika |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $12.80 | 2025 | |
| Allergan, INC. | $11.39 | 2020 | |
| Roche Diagnostics Corporation | $11.18 | 2019 | |
| Organon LLC | $10.49 | 2023 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tammy Herrick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.